title: A diagnostic paradigm for resectable liver lesions: to biopsy or not to biopsy?
abstract: BACKGROUND
  Despite a growing body of evidence reporting the deleterious mechanical and oncological complications of biopsy of hepatic malignancy, a small but significant number of patients undergo the procedure prior to specialist surgical referral. Biopsy has been shown to result in poorer longterm survival following resection and advances in modern imaging modalities provide equivalent, or better, diagnostic accuracy.
  
  
  METHODS
  The literature relating to needle-tract seeding of primary and secondary liver cancers was reviewed. MEDLINE, EMBASE and the Cochrane Library were searched for case reports and series relating to the oncological complications of biopsy of liver malignancies. Current non-invasive diagnostic modalities are reviewed and their diagnostic accuracy presented.
  
  
  RESULTS
  Biopsy of malignant liver lesions has been shown to result in poorer longterm survival following resection and does not confer any diagnostic advantage over a combination of non-invasive imaging techniques and serum tumour markers.
  
  
  CONCLUSIONS
  Given that chemotherapeutic advances now often permit downstaging and subsequent resection of 'unresectable' disease, the time has come to abandon biopsy of solid lesions outside the setting of a specialist multi-disciplinary team meeting (MDT).
authors.affiliation: Basingstoke Hepatobiliary Unit, Basingstoke and North Hampshire Hospitals NHS Foundation Trust Basingstoke, UK.
authors.forename: Adrian B
authors.initials: AB
authors.lastname: Cresswell
authors.forename: Fenella K S
authors.initials: FK
authors.lastname: Welsh
authors.forename: Myrddin
authors.initials: M
authors.lastname: Rees